AfterRaise/Companies/TriGemX Bio

TriGemX Bio

$94M UndisclosedRaised yesterdayUSAOtherUSA
Visit website →

In their own words

What TriGemX Bio says it is doing

Work here? Claim your company profile
Research and development

Public signal Read from the company's own description of what the funding supports.

Why now

Where TriGemX Bio is today

TriGemX Bio announced a funding round of $94M on 1 October 2026, led by The Column Group.

Latest round
Undisclosed
Amount
$94M
Announced
1 October 2026
Headquarters
USA
Sector
Other
Growth stage
Growth
Investors
Also participating
Relevant leadership
CEO Jeff Goater

Momentum AfterRaise intelligence

AfterRaise Score

69
Building momentum
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
19/25
round size relative to the market
Funding stage
10/20
Undisclosed
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 1 October 2026
    $94M raised
    Led by The Column Group.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • Research programme expansion
  • Scientific team growth
  • Accelerated hiring across functions
  • Operational scale

Opportunities this could create

  • Operations hiring
  • Scientific advisers
  • Research operations
  • Specialist suppliers
  • Commercial leadership

Based on the Other sector, a Growth round and the priorities the company itself set out. Not a statement of fact.

Medium momentum2 connected signals
  • 1 October 2026$94M round announced
  • 1 October 2026Stated priority: research and development

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What TriGemX Bio is open to

Not yet specified

TriGemX Bio has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with TriGemX Bio

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at TriGemX Bio?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: the roles and projects you have open. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Other companies

See the sector